Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
Article in JAMA Oncology (June 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Effects of metformin and silodosin as supplementary treatments to abiraterone on human telomerase reverse transcriptase (hTERT) level in metastatic castration-resistant prostate cancer (mCRPC) cells: An in vitro study
Article in Narra J (March 2024)
Addressing controversial areas in the management of advanced prostate cancer in Canada : Areas of consensus and controversy from the third Canadian consensus forum
Article in Canadian Urological Association Journal (December 2023)